These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2972246)

  • 21. Class I antigen presentation.
    Jelachich ML; Biddison WE
    Year Immunol; 1989; 4():41-58. PubMed ID: 2522701
    [No Abstract]   [Full Text] [Related]  

  • 22. Failure of intravenously infused spleen cells bearing a minor histoincompatibility to delay rejection of skin grafts bearing additional antigens.
    Johnson LL
    Transplantation; 1988 Jul; 46(1):132-7. PubMed ID: 3293274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice.
    Wecker H; Grusby MJ; Auchincloss H
    Transplantation; 1995 Apr; 59(8):1223-7. PubMed ID: 7732570
    [No Abstract]   [Full Text] [Related]  

  • 24. H-Y antibodies recognize the H-Y transplantation antigen.
    Wachtel GM; Wachtel SS; Nakamura D; Moreira-Filho CA; Brunner M; Koo GC
    Transplantation; 1984 Jan; 37(1):8-13. PubMed ID: 6364493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The H-Y antigen and its role in natural transplantation.
    Billingham RE; Hings IM
    Hum Genet; 1981; 58(1):9-17. PubMed ID: 7026417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerance induction of allo-class I H-2 antigen-reactive Lyt-2+ helper T cells and prolonged survival of the corresponding class I H-2-disparate skin graft.
    Azuma T; Sato S; Kitagawa S; Hori S; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Jul; 143(1):1-8. PubMed ID: 2525143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
    Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
    J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.
    Murphy WJ; Kumar V; Bennett M
    J Exp Med; 1987 Nov; 166(5):1499-509. PubMed ID: 3316472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that the effector mechanism of skin allograft rejection is antigen-specific.
    Rosenberg AS; Singer A
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7739-42. PubMed ID: 2459716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular peptide composition governed by major histocompatibility complex class I molecules.
    Falk K; Rötzschke O; Rammensee HG
    Nature; 1990 Nov; 348(6298):248-51. PubMed ID: 2234092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.
    Rosenberg AS; Mizuochi T; Sharrow SO; Singer A
    J Exp Med; 1987 May; 165(5):1296-315. PubMed ID: 2437237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
    Nevala WK; Paul C; Wettstein PJ
    J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway.
    Rodriguez-Barbosa JI; Fernandez-Renedo C; Moral AMB; Bühler L; Del Rio ML
    Cell Mol Immunol; 2017 Jun; 14(6):497-510. PubMed ID: 26924526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of rejection of MHC class I-disparate murine skin grafts--histological and immunohistochemical studies of the rejection phenomenon.
    Kobayashi E; Kawai K; Ito M; Matsumoto Y; Fujiwara M
    Transplant Proc; 1990 Oct; 22(5):2352-7. PubMed ID: 2219400
    [No Abstract]   [Full Text] [Related]  

  • 36. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
    Halliday GM; Odling KA; Muller HK
    Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour-induced immunity to H-Y-disparate skin grafts without concomitant priming of CTL.
    Johnson LL; Hines DL
    Immunology; 1990 Jan; 69(1):85-90. PubMed ID: 2312158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cell recognition of donor class I major histocompatibility complex peptides during allograft rejection.
    Fangmann J; Dalchau R; Sawyer GJ; Priestley CA; Fabre JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):187-8. PubMed ID: 8438268
    [No Abstract]   [Full Text] [Related]  

  • 39. The influence of graft size on the induction of immunity versus tolerance to H-Y in H-2k strains of mice.
    Ashman RB
    Immunogenetics; 1985; 22(6):585-91. PubMed ID: 3908302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rejection of allo-or xenografts of lymphoid cells by nude mice: T cell suicide as a result of cooperation between histoincompatible T and B cells.
    Piguet PF; Vassalli P
    J Immunol; 1978 Jan; 120(1):79-85. PubMed ID: 24074
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.